• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » MassDevice podcast: Hamilton Thorne CEO Meg Spencer

MassDevice podcast: Hamilton Thorne CEO Meg Spencer

April 15, 2011 By Christian Holland

Laser-based lab equipment maker Hamilton Thorne Inc. (CVE:HTL) derives a major part of its revenues from the life sciences R&D market. CEO Meg Spencer says that requires the company to surf the leading edge of several life science research waves, including stem cells and regenerative medicine.

The Beverly, Mass.-based company looks to help solve some of the problems scientists encounter as they develop their research on stem cells into regenerative medicine techniques. Those often involve the growth of millions — or even billions — of cells, so anything that can accelerate or automate that process is vital to innovation in the space.

Click here to listen to MassDevice’s interview with Meg Spencer. You can also download an MP3 of the interview by right-clicking.

Scientists can’t count on that many cells growing uniformly without some care and feeding. Keeping cultures that size clean of irregular cells is a 24/7/365 job. Enter Hamilton Thorne’s Stiletto and Staccato devices, which are designed to cultivate the cultures, relieving researchers of hours of tedium.

The company’s XYClone laser with Staccato option being used for inner cell mass excision
Video courtesy Nikica Zaninovic, et al. of the Weill Cornell Medical College of Cornell University

The company is hoping that what Spencer calls its “wow factor” is enough to catch the rising tide in regenerative science, focusing its sales and marketing efforts on creating an installed base of labs doing cutting-edge work. Hamilton Thorne has had some notable successes on that front.* Scientists from Cornell University’s Weill Lab recently published a paper evidencing the Staccato product’s ability to increase their productivity 10-fold.

The company also lays claim to 90 percent of the U.S. laser fertility market, according to Spencer. Clinicians use the company’s lasers to facilitate pre-implantation genetic screening or even to prime the wall of an embryo for implantation with its FDA-cleared Zilos-tk laser.

Although Hamilton THorne has yet to post a profit — it recently replenished its coffers with a $650,000 debt offering (PDF) — the company’s financials are improving. Sales during the nine months ended Sept. 30, 2010, were a full 25 percent above the same period from the previous year, rising to $4.5 million. Its full 2010 results are due April 21.

Click here to listen to MassDevice’s interview with Hamilton Thorne CEO Meg Spencer. You can also download an MP3 of the interview by right-clicking.

*Correction, April 15, 2011: This article originally mis-identified Hamilton Thorne as a participant in a study published in Nature. Return to the corrected sentence.

Filed Under: Device Talks Podcasts, Lab Instruments & Supplies, News Well, Regenerative Medicine, Stem Cells Tagged With: Hamilton Thorne Inc., MassDevice Q&A

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy